Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Scope & Guideline
Fostering collaboration in the fight against dementia.
Introduction
Aims and Scopes
- Multimodal Biomarkers and Diagnostic Techniques:
Research involving cerebrospinal fluid (CSF), blood-based biomarkers, neuroimaging, and genetic factors to improve the diagnosis and understanding of Alzheimer's disease pathology. - Cognitive Assessment and Monitoring Tools:
Development and validation of cognitive assessment tools, including digital and remote testing methods, aimed at early detection and monitoring of cognitive decline. - Neuropsychiatric Symptoms and Behavioral Factors:
Exploration of the relationship between neuropsychiatric symptoms, behavioral changes, and cognitive impairment in dementia patients. - Lifestyle and Environmental Influences:
Studies examining the impact of lifestyle factors, such as physical activity, diet, and socioeconomic status, on cognitive health and dementia risk. - Health Disparities and Ethnic Variability:
Research addressing the differences in dementia prevalence, risk factors, and outcomes across diverse populations, focusing on health equity and access to care. - Technological Innovations in Research:
Utilization of machine learning, artificial intelligence, and digital health technologies for improving diagnostic precision and understanding of cognitive decline.
Trending and Emerging
- AI and Machine Learning Applications:
There is a rising trend in utilizing AI and machine learning techniques to analyze cognitive decline, identify biomarkers, and improve diagnostic accuracy. - Integration of Lifestyle Factors:
An increasing number of studies are focusing on how lifestyle factors, such as nutrition, physical activity, and social engagement, influence cognitive health and dementia risk. - Biomarker Discovery and Validation:
Research on novel biomarkers, particularly blood-based and neuroimaging biomarkers, is gaining traction as a means to enhance early detection and monitoring of Alzheimer's disease. - Cultural and Social Determinants of Health:
A growing interest in understanding how cultural and social determinants influence dementia prevalence and outcomes, particularly in diverse populations, is evident in recent publications. - Digital Health Interventions:
Emerging interest in digital tools and remote monitoring technologies for assessing cognitive function and delivering interventions, especially in the context of the COVID-19 pandemic. - Comorbidity and Multimorbidity Research:
Research exploring the interactions between Alzheimer's disease and other chronic conditions, highlighting the complexity of patient care and the need for integrated health strategies.
Declining or Waning
- Traditional Cognitive Assessment Methods:
There has been a noticeable decrease in studies solely focused on conventional cognitive assessments, as the field moves towards more innovative and diverse methods of evaluation. - Single-Factor Risk Assessments:
Research that examines isolated risk factors for dementia without considering the multimodal interactions has become less common, with a growing emphasis on comprehensive, integrative approaches. - Aging without Cognitive Decline Focus:
Studies that exclusively investigate aging without a direct connection to cognitive decline or dementia have diminished, as the focus shifts towards understanding the cognitive trajectories related to aging. - Generalized Dementia Studies:
Research that does not differentiate between types of dementia (e.g., Alzheimer’s versus Lewy body dementia) is less frequent, as there is a growing recognition of the need for subtype-specific investigations.
Similar Journals
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
Bridging Disciplines: The Nexus of Psychology and NeurologyARCHIVES OF CLINICAL NEUROPSYCHOLOGY is a premier academic journal dedicated to the vital intersections of clinical psychology, neuropsychology, and psychiatry, offering researchers and clinicians a platform to publish cutting-edge findings and comprehensive reviews. Published by Oxford University Press, the journal aims to advance the understanding of the cognitive and psychological aspects of neurological conditions through rigorous empirical research and innovative methodologies. With an impressive range of quartile rankings, including Q2 in Clinical Psychology and Neuropsychology, the journal stands out for its commitment to enhancing clinical practices and improving patient outcomes. Although it does not offer open access, its reputation is underscored by a competitive impact factor, making it a critical resource for professionals in the field looking to stay informed on the latest developments. The journal has been a respected outlet since 1986, and as it continues into 2024, it remains a beacon for scholarly discourse in neuropsychology and mental health.
Alzheimers & Dementia-Translational Research & Clinical Interventions
Advancing Knowledge, Improving Lives in Dementia CareAlzheimer's & Dementia: Translational Research & Clinical Interventions, published by WILEY, is a premier open-access journal that has been at the forefront of innovations in the field of neurology and psychiatry since its inception in 2015. With an impressive impact factor reflecting its high-quality research contributions, this journal has been designated as Q1 in both Neurology (Clinical) and Psychiatry and Mental Health categories for 2023, ranking in the top percentiles of their respective Scopus fields. The journal aims to bridge the gap between research and clinical practice, promoting the translation of scientific discoveries into real-world applications for Alzheimer's disease and other dementias. Positioned in the United States, it is a valuable resource for researchers, clinicians, and students dedicated to advancing knowledge and treatment approaches in these critical areas. With its commitment to open access, the journal ensures that vital research is accessible to a broad audience, fostering collaboration and knowledge sharing across the global scientific community.
Journal of Clinical Neurology
Leading the Charge in Neurological InnovationThe Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.
Dementia and Geriatric Cognitive Disorders Extra
Advancing knowledge in cognitive health and aging.Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Fostering interdisciplinary dialogue in dementia research.DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.
Cognitive and Behavioral Neurology
Elevating Knowledge in Cognitive and Behavioral NeurologyCognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.
NEUROBIOLOGY OF AGING
Unraveling the Mysteries of Aging and the BrainNEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
Bridging clinical practice and experimental insights.The Journal of Clinical and Experimental Neuropsychology, published by Taylor & Francis Inc, stands as a pivotal resource in the realms of clinical psychology and neuropsychology. With an ISSN of 1380-3395 and an E-ISSN of 1744-411X, this journal has been a hallmark of scholarly excellence since its inception in 1985, continuing to shape the fields until 2024. It is renowned for its rigorous peer-reviewed articles and has garnered significant recognition, achieving a Q2 ranking in Clinical Psychology and Q3 rankings in various other relevant categories as of 2023. Serving as a bridge between clinical practice and experimental research, the journal underscores the critical role of neuropsychological assessment and intervention in enhancing mental health outcomes. Although not an open-access journal, it provides significant insights and empirical data that are crucial for researchers, clinicians, and students dedicated to advancing the understanding of cognitive functioning and psychological health. The journal's commitment to disseminating high-quality research contributes to its reputation and impact, making it a vital resource for those engaged in the study of neuropsychology and its clinical applications.
Cognitive Neuropsychiatry
Advancing Insights: Where Cognitive Science Meets Mental HealthCognitive Neuropsychiatry is a distinguished academic journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to the intersection of cognitive neuroscience and psychiatry. With a strong commitment to advancing knowledge in these rapidly evolving fields, this journal provides a platform for high-quality, peer-reviewed research that explores cognitive processes underlying psychiatric disorders. Aiming to bridge gaps between neuroscience and clinical practice, it serves as an essential resource for researchers, professionals, and students alike. As evidenced by its performance metrics, the journal ranks in the Q2 quartile for Psychiatry and Mental Health, and Q3 for Cognitive Neuroscience, showcasing its relevance and growing impact, particularly among a competitive audience. While it does not currently offer open access options, Cognitive Neuropsychiatry remains a vital outlet for disseminating impactful findings, offering insights that shape contemporary psychiatric understanding and interventions.
BEHAVIOURAL NEUROLOGY
Unlocking Potential: Researching the Neurological Foundations of BehaviorBEHAVIOURAL NEUROLOGY is a distinguished open-access journal published by Hindawi Ltd, dedicated to advancing the field of neurology and neuropsychology since its inception in 1988. With ISSN: 0953-4180 and E-ISSN: 1875-8584, this journal provides a platform for innovative research and interdisciplinary studies that explore the intricate connections between behavior and neurological processes. Housed in the Netherlands, BEHAVIOURAL NEUROLOGY enjoys a commendable reputation, boasting impressive quartile rankings of Q2 in various medical and psychological categories, reflecting its significant contribution to the literature with a focus on clinical neurology and physiological psychology. The journal's rigorous peer-review process ensures that published works meet high academic standards, making it an essential resource for researchers, clinicians, and students seeking to deepen their understanding of neurological disorders and cognitive function. As of 2023, it ranks in the 80th percentile in neuropsychology, further underscoring its impact and relevance in the scientific community. For those interested in accessible knowledge, BEHAVIOURAL NEUROLOGY's commitment to open access facilitates the dissemination of groundbreaking research, allowing a wider audience to engage with critical advancements in the field.